The global enteral feeding formulas market was valued at USD 5,330.6 million in 2019. Rise in premature births is one of the main factors propelling demand for sip feeds to cater to the nutritional requirements of the newborns. The rise in technological advancements of enteral feeding formulas and growing chronic diseases are the factors that are propelling the growth of the global enteral feeding formulas market.

Adroit Market Research report on global enteral feeding formulas market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years 2018, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global enteral feeding formulas market have been studied in detail.

The global enteral feeding formula market is growing due to rising chronic diseases and disorders, increasing geriatric populations, increasing premature birth prevalence, high health care costs, and high demand for home care. The second largest cause of death worldwide, chronic diseases such as cancer, accounted for 8.8 million deaths in 2015. Due to the lower penetration, especially among the geriatric and paediatric patient population, the enteral food segment is presently in the uncharted or unexplored and compared to the oral food segment. However, due to the rising demand for technologically advanced goods, including enteral feeding pumps, used to deliver medical foods, this route is expected to see the fastest growth in the future. Through these enteral feeding products, companies are increasingly concentrating on improving patient mobility and safety. In addition, the understanding among patients and doctors of the choices available on the market makes it easier to select the best route for nutrient administration based on varying patient requirements.

The global enteral feeding formulas market has been segmented based on product type, indication type, flow type, stage, end-users and region. Based on product type, standard formula segment dominated the market in 2019 due to the rising demand for standard tube feeds among volume sensitive patients or patients suffering from congestive heart failure, Syndrome of Inappropriate Diuretic Hormone (SIADH), and renal failure. On the basis of indication type, other indications, followed by cancer care dominated the market in 2019, due to the rising occurrence of malnutrition associated with the weakening of the immune system in critically ill patients. On the basis of flow type,  the intermittent feeding flow segment dominated the market as it does not require any feeding pumps, which allows greater mobility between the feedings. This is expected to increase its adoption among hospital and homecare settings, thereby positively impacting the segment growth. On the basis of stage type, the adults segment dominated the market in 2019 due to the high commercial availability of tube feed among adults and rising adoption. The syringe technique, gravity drip technique, and the pump system can be used for enteral feeding in adults. Based on end-users, home care segment dominated the market in 2019 due to the increasing adoption of enteral feeding formulas by home healthcare patients and increasing government intervention to educate the patient population on the use of enteral feeding pumps or systems. In collaboration with the National Institute for Clinical Excellence ( NICE), the newly developed strategy has revolutionised nutrition supplements for patient health care facilities and increased service quality.

North America dominated the global enteral feeding formulas market in 2019. Rapid adoption of technologies in healthcare. One of the main factors driving the regional market is high knowledge of medical nutrition, the involvement of key players and numerous initiatives to reduce the incidence of disease-related malnutrition. Latin America is anticipated to witness the fastest growth during the forecast period owing to the growing geriatric population and the increasing prevalence of chronic diseases are some of the key factors driving the regional market.

Key players operating in the global enteral feeding formulas market include Nestle Health Science, Danone Nutricia, Abbott Nutrition, Primus Pharmaceuticals, Inc., Mead Johnson & Company, LLC, Fresenius Kabi AG, Meiji Holdings Co., Ltd., and Victus among others.

Key Segments of the Global Enteral Feeding Formulas Market  

Product Type Overview, 2018-2028 (USD Million)

• Standard Formula
• Disease-Specific Formula

Indication Type Overview, 2018-2028 (USD Million)

• Alzheimer’s
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Flow Type Overview, 2018-2028 (USD Million)

• Intermittent Feeding Flow
• Continuous Feeding Flow

Stage Overview, 2018-2028 (USD Million)

• Adults
• Pediatrics

End-Users Overview, 2018-2028 (USD Million)

• Hospitals
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
• Home Care

Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa